Package Leaflet: Information for the Patient
Pregabalin OPKO 75 mg Hard Capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Pregabalin belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain: Pregabalin is used to treat long-standing pain caused by damage to the nerves. There are several diseases that can cause peripheral neuropathic pain, such as diabetes or shingles. The feeling of pain can be described as heat, burning, throbbing, stabbing, sharp, aching, cramping, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social activity and overall quality of life.
Epilepsy: Pregabalin is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalin to treat epilepsy when your current treatment is not controlling your condition. You should take pregabalin in addition to your current treatment. Pregabalin should not be used alone but should always be used in combination with other anti-epileptic treatments.
Generalized anxiety disorder: Pregabalin is used to treat generalized anxiety disorder (GAD). The symptoms of GAD are prolonged and excessive worry and anxiety that are difficult to control. Generalized anxiety disorder can also cause restlessness or feeling on edge or nervousness, feeling tired (fatigue) easily, difficulty concentrating or mind going blank, irritability, muscle tension or sleep disturbances. This is different from the stress and tension of everyday life.
Do not take Pregabalin OPKO
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before taking pregabalin.
Dependence
Some people may become dependent on pregabalin (need to keep taking the medicine). They may have withdrawal effects when they stop taking pregabalin (see section 3, "How to take Pregabalin OPKO" and "If you stop taking Pregabalin OPKO"). If you are concerned that you may become dependent on pregabalin, it is important that you consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these, talk to your doctor to discuss the best course of treatment for you, including when it is appropriate to stop and how to do so safely.
Children and adolescents
The safety and efficacy in children and adolescents (under 18 years) have not been established, so pregabalin should not be used in this age group.
Other medicines and Pregabalin OPKO
Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Pregabalin and some other medicines may affect each other (interact). When used with certain medicines that have sedating effects (including opioids), pregabalin may increase these effects and cause respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with medicines that contain:
Oxycodone - (used as a painkiller)
Lorazepam - (used to treat anxiety)
Alcohol
Pregabalin can be taken with oral contraceptives.
Pregabalin OPKO with food and alcohol
Pregabalin capsules can be taken with or without food.
It is advised not to drink alcohol while taking pregabalin.
Pregnancy, breastfeeding, and fertility
Pregabalin should not be taken during pregnancy or breastfeeding, unless your doctor has told you to do so. The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 out of 100 babies had congenital malformations. This compares to 4 babies out of 100 born to women not treated with pregabalin in the study. There have been reports of malformations of the face (orofacial clefts), eyes, nervous system (including the brain), kidneys, and genitals.
An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
Pregabalin OPKO contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per hard capsule; this is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist. Do not take more medicine than prescribed.
Your doctor will determine the appropriate dose for you.
Pregabalin OPKO is for oral use only.
Peripheral and central neuropathic pain, epilepsy, or Generalized Anxiety Disorder:
If you think that the effect of pregabalin is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take pregabalin as normal, except if you have kidney problems.
Your doctor may prescribe a different dosing regimen or dose if you have kidney problems.
Swallow the capsule whole with water.
Continue taking pregabalin until your doctor tells you to stop.
If you take more Pregabalin OPKO than you should
Contact your doctor or go to the nearest hospital emergency department immediately. Take your capsule box or bottle with you. You may feel drowsy, confused, agitated, or restless as a result of taking more pregabalin than you should. There have also been reports of seizures and loss of consciousness (coma).
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Pregabalin OPKO
It is important that you take your pregabalin capsules regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. In that case, just continue with the next dose as usual. Do not take a double dose to make up for a forgotten dose.
If you stop taking Pregabalin OPKO
Do not stop taking pregabalin suddenly. If you want to stop taking pregabalin, talk to your doctor first. He will tell you how to do it. If treatment is stopped, it should be done gradually over a minimum of one week.
Once you have finished short- or long-term treatment with pregabalin, you should be aware that you may experience certain side effects, known as withdrawal effects. These effects include sleep problems, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, depression, suicidal thoughts, pain, sweating, and dizziness. These effects may occur more frequently or severely if you have been taking pregabalin for a longer period. If you experience withdrawal effects, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
• Throat pain.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
• Convulsions.
Very Rare: may affect up to 1 in 10,000 people
Frequency Not Known: frequency cannot be estimated from available data
After interrupting short- or long-term treatment with pregabalin, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop treatment with Pregabalin OPKO").
If you experience swelling in the face or tongue, or if your skin turns red and has blisters or peeling, you should seek medical attention immediately.
Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity, which have similar adverse effects to those of pregabalin, so the intensity of these effects may increase when taken together.
The following adverse reactions have been reported in post-marketing experience: difficulty breathing, shallow breathing.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiration date indicated on the outer packaging (CAD). The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer use. This way, you will help protect the environment.
Composition of Pregabalin OPKO:
Capsule content:
The active ingredient is pregabalin. Each capsule contains 75 mg of pregabalin.
Excipients: Cornstarch (Starcap1500) Talc
Capsule shell:
Purified water
Titanium dioxide (E 171)
Sodium lauryl sulfate
Red iron oxide (E172)
Gelatin.
Black ink (lacquer (E904), black iron oxide (E172), potassium hydroxide)
Appearance of Pregabalin OPKO and Package Contents
Pregabalin OPKO 75 mg; Size '4', hard gelatin capsule with orange opaque cap and white opaque body, marked with '1360' on the cap and with '75' on the body with black ink containing white to off-white powder.
Pregabalin OPKO is available in packages of 56 hard capsules, approximately 14.4 mm long; in PVC/PVDC/Al blisters.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
OPKO Health Spain, S.L.U.
Pl. Europa 13-15, 08908
L'Hospitalet de Llobregat (Barcelona)
Spain
Manufacturer
Laboratori Fundació Dau
C/ C, 12-14 Pol. Ind. Zona Franca,
08040 Barcelona,
Spain
Date of Last Revision of this Prospectus: August 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)